Agenda: - Validation Harmonized Protocol: update - Validation vs pathology - Hippocampal Label Expansion project: update - News - Congress presentations.

Slides:



Advertisements
Similar presentations
Agenda: - Certification Platform: performance for training - I round - II round -Feedback from naives - Beta testers proposals - Congress presentations.
Advertisements

Esri International User Conference | San Diego, CA Demo Theater | ArcGIS Beta Community and ArcGIS 10.1 Beta Program Mike Hogan & Rohit Gupta July 12 th,
Agenda: - Update master tracers - Update validation vs pathology - Hippocampal 3D Object for AR Visualization - Papers - Next congress presentations &
WP4 – Task 4.4 LCA Activities
Development of a harmonized protocol for hippocampal tracing An EADC-ADNI joint effort 4 th Meeting, Paris, July 20, 2011 Principal Investigators: Giovanni.
Agenda: - Validation vs Pathology - Congress presentations & Meetings - Paper publication VI PMT meeting – Feb 1, 2011.
Answers to previous TC issues: - Demographic features of the selected subjects (age, sex, disease, ApoE) - Check for SIEMENS-Allegra scans at 3T for the.
Comprehensive Organizational Health AssessmentMay 2012Butler Institute for Families Comprehensive Organizational Health Assessment Presented by: Robin.
Agenda: - Hippocampal Label Expansion project - Certification Platform: performance/criteria - Questionnaire - Congress presentations - Papers XV PMT meeting.
Agenda: - Update on master tracers’ segmentation check - Update validation vs pathology - PMT application submission of “Study on the validation of VSRAD”
CTE Credential Program For IHE and District Representatives Meetings held March & April 2010.
Agenda: - New benchmark ICC and Dice’s - Training set for Naïve - Beta testers proposals - Congress presentations XII PMT meeting – September 26, 2012.
Agenda: - Axes check - Validation vs Pathology - Paper Publications - Congress presentations & Meetings VII PMT meeting – Feb 29, 2012.
Agenda: - Certification Platform: Training - I round - Beta testers proposals - Congress presentations - Paper “check for axes” XIII PMT meeting – October.
Disclosures/Conflicts Consulting: GE Healthcare Bayer Abbott Elan/Janssen Synarc Genentech Merck.
CSF tau Is it an informative biomarker of AD pathology Chris Clark Alzheimer’s Disease Center University of Pennsylvania.
Usable Privacy and Security Carnegie Mellon University Spring 2008 Lorrie Cranor 1 Designing user studies February.
MCI Clinical Trial Design FDA Advisory Committee Meeting March 13, 2001 Gaithersburg, MD Michael Grundman, MD, MPH Alzheimer’s Disease Cooperative Study.
Brain Changes in 676 ADNI subjects: Summary of 10 Studies using Tensor Based Morphometry & Automated Hippocampal Maps Paul Thompson and the UCLA ADNI.
Development of a harmonized protocol for hippocampal tracing An EADC-ADNI joint effort 1 th Project Management Team Meeting August 31, 2011.
East Central Regional Center Ohio College Tech Prep SCTAI Update September 26, 2012 Secondary Career-Technical Alignment Initiative (SCTAI)
Welcome to the iTEC People & Events Directory … key points!
December 2010iTEC - Designing the future classroom1 Virginija Birenienė iTEC community moderator iTEC Edukata tools in Education.
EPAD update José Luis Molinuevo Worldwide-ADNI Update Meeting Friday, July 17, 2015 Washington, D.C.
Defining Mild Cognitive Impairment Steven T.DeKosky, M.D. Director, Alzheimer’s Disease Research Center University of Pittsburgh Pittsburgh, PA.
Second Annual Japan CDISC Group (JCG) Meeting 28 January 2004 Julie Evans Director, Technical Services.
Agenda: - Axes check - Validation vs Pathology - Publication Policy - Paper Publications - Congress presentations & Meetings VIII PMT meeting – Mar 21,
Alison Evans Richard Sloan National Project Marking Schedule.
3rd NRC Meeting, 9-12 June 2008, Windsor ICCS 2009 Main Survey Field Operations.
Core Outcome Domains for Eczema – Results of a Delphi Consensus Project Introduction Eczema is a chronic, relapsing, inflammatory skin disorder that affects.
Imaging Core Laboratory Fall Meeting, 2011 Imaging Challenges for ACRIN sites Compliance and set-up Anthony M. Levering Assistant Director, Core lab.
2004 All Hands Meeting Morphometry BIRN: Milestones for 2005 Jorge Jovicich PhD Steve Pieper, PhD David Kennedy, PhD.
The Results of Automated Image Analysis Workshop at the 10th European Congress on Telepathology and 4th International Congress on Virtual Microscopy Arvydas.
HOW CAN NEUROIMAGING HELP UNDERSTAND, DIAGNOSE, AND DEVELOP TREATMENTS FOR ALZHEIMER'S DISEASE? Part C – AD brain scans - anatomical NUCLEAR MEDICINE GRAND.
Disclosure of research results: should policies be changed? Melanie B. Shulman, M.D., M.Phil. Clinical Associate Professor of Neurology and Psychiatry.
March 10th, 2014 Efficacy Endpoints for Anticonvulsant Therapies Interview 1.
Federal Aviation Administration SL-1 Federal Aviation Administration Safety Management Systems for Design and Manufacturing Organizations Part III Wrap.
MRI as a Potential Surrogate Marker in the ADCS MCI Trial
©2012 MFMER | ADNI Clinical Core Paul Aisen Ron Petersen Michael Donohue Jennifer Salazar WW ADNI Washington, DC July 17, 2015.
Wei Chen CCNI Journal Club Alzheimer’s disease (AD): imaging & cognition imaging & cognition.
AAN –Toronto, April 11, 2010 Development of a harmonized protocol for hippocampal tracing An EADC-ADNI joint effort METHODS.
PharmaCog WP5 / E-ADNI. Enrollment and follow-ups Clinical sites Maximum Minimum PATIENTS EXPECTED.
UCI Progress MBIRN AHM. Progress Tool Development –FIPS and HID: Modifications to store derived data, including morphometric measures from Freesurfer.
Population of 4D Computational Phantoms for CT Imaging Research and Dosimetry W. Paul Segars, PhD Carl E. Ravin Advanced Imaging Labs Duke University.
C-HOBIC FINDINGS VALIDATION - REPORT AND CONSENSUS ACTIVITY Kathryn Hannah, Anne Casey, Zac Whitewood-Moores C-HOBIC.
Malta-Surveys: Online Polls May 2014.
Apolipoprotein E and Gray Matter Loss in Mild Cognitive Impairment and Alzheimer’s Disease Spampinato MV, Goldsberry G, Mintzer J, Rumboldt Z Medical University.
Accuracy, Reliability, and Validity of Freesurfer Measurements David H. Salat
Laboratory of Neuro Imaging: Graduate Students Sarah K. Madsen Mentor: Paul M. Thompson, Ph.D. Committee: Susan Y. Bookheimer, Ph.D., Jamie D. Feusner,
PDS4 Project Report PDS MC F2F University of Maryland Dan Crichton March 27,
Kim HS Introduction considering that the amount of MRI data to analyze in present-day clinical trials is often on the order of hundreds or.
Parkinson’s Disease: Updating the UPDRS February 20, 2014 Glenn T. Stebbins, PhD Department of Neurological Sciences Rush University Medical Center Chicago,
DEVELOPING AND TESTING THE STANDARD OF PRACTICE AND EVALUATION OF CRITICAL-CARE-NURSING TOOL (SPECT) FOR GRADUATES OF CRITICAL CARE NURSE EDUCATION PROGRAMS.
Training for Scheduling of Students with Disabilities in Secondary Schools Debra Y. Barbour Office of Low Incidence and Inclusion May 2008.
Leader Name (Passport name) Major Nationality Graduate period or
Leader Name (Passport name) Major Nationality Graduate period or
Alzheimer’s Disease Neuroimaging Initiative 3 (ADNI 3)
MTL SUBREGIONAL MORPHOMETRY USING HIGH RESOLUTION MRI IN ADNI2
Psyc 351 Measurement Techniques
By Dr Shewikar Farrag Dr Nehad Sabry
Imaging AD Progression Amyloid Imaging Agents.
Tennessee Longitudinal Data system (TLDS)
ADNI Clinical Core Paul Aisen Ron Petersen Michael Donohue
CT images by texture analysis
Data & Learning Team February 1, 2018.
Marianne Wehby Skills Engagement Executive
Marianne Wehby Skills Engagement Executive
MultiModality Registration using Hilbert-Schmidt Estimators
EMIS Advisory Council Marianne Mottley Report Card Project Director
MS-SEG Challenge: Results and Analysis on Testing Data
Presentation transcript:

Agenda: - Validation Harmonized Protocol: update - Validation vs pathology - Hippocampal Label Expansion project: update - News - Congress presentations - Papers XVIII PMT meeting – June 5, 2013

Validation versus pathology 1 tracer (Greg) Segmentation based on Harmonized Protocol: Analysis based on the information available for each dataset and vs Bobinsky’s paper Mayo Clinic AD + CTRL + MCI dataset with pathologically confirmed diagnosis (Braak’s stages), but not postmortem hippocampal measurement Mony DeLeon 15 AD + 5 CTRL at 1.5T postmortem MRI and quantitative histology (possible additional AD cases) (Bobinsky paper on 9 AD+4 NL sbj scanned with Philips) 15 Philips + 18 GE 13 post-mortem 10 post-m T1 PD 50 antem

de Leon GE PD

Partial volume??

de Leon Philips T1

Hippocampal Label Expansion project: update Subjects = 135 Hippocampi = 270 MRItracertracing QC/correction Certification 68/ TMasamiCompleteI-II Complete (67 3T) 30/30DominikCompleteI-II Complete 12/12RossanaCompleteI-II Complete 10/10MartinaComplete I-II Complete 15/15MichelComplete I-II Complete

SD received all of the certified labels Tracers are Masters or platform-Qualified. Anyway, exact ICCs across the 5 can be computed using the volumes of the Qualification round. PLATFORM - SD has tech support from PAVI, at Université de Sherbrooke -They are looking into file formats for the contours - SD has scheduled a meeting with the Technical Advisory group Hippocampal Label Expansion project: SD update

News: Subfields Group composed by Paul Yushkevich, Susan Mueller and Lei Wang aims to converge hippo-subfields imagers for protocol harmonization. They asked for our participation, to tune the protocols and import harmonizaton methods. We are invited to present the Hippo Harmonization project a-remoto to their HS3 meeting, June

News: Duvernoy Duvernoy explained some unclear anatomy issues and approved: AC-PC standard orientation Inclusion of “vestigial” tissue Choices of the Delphi panel Participation as a coauthor

NEXT HARMONIZATION MEETING: JULY 17 H AIC-AAIC (Boston, July 13-18, 2013) Training of Naïve Tracers; Statistics for Certification Platform POSTERS - AIC-AAIC developing topics Validation phase 1: preliminary data; Expansion project: preliminary data on 1.5T images SUBMITTED -CTAD (San Diego, Nov 3-5, 2011) Validation phase 1: preliminary data; Expansion project: preliminary data on 1.5T images SUBMITTED Congress Presentations

Papers 1)Survey of protocols (preliminary phase; JAD 2011) 2)Operationalization (preliminary phase; Alzheimer’s & Dementia, published online) 3)Axes check short report (Brescia Team, ADJ-D , I revision) 4)Master tracers’ practice and reliability (Brescia Team, Sent to coauthors) 5)Development of certification platform (Duchesne and coll) 6)Consensual Protocol definition (Brescia Team – companion paper 1) 7)Validation data (Brescia Team – companion paper 2) 8)Validation vs pathology (TBD) DONE ONGOING PLANNED

VALIDATION VS CURRENT PROTOCOLS ASSESSMENT OF SOURCES OF VARIANCE TRAINING SET DEVELOPMENT VALIDATION VS PATHOLOGY GOLD STANDARD Harmonized Protocol ADNI scans: 2 x 5 Scheltens’s atrophy score x 2 sides x 2 magnet strengths (1.5-3T) Total per rater: 40 hippos Harmonized Protocol ADNI scans: 2 sides x 5 Scheltens’s atrophy scores x 3 time points (bl-1y-2y) x 3 scanners (+ bl) x 2 magnet strengths (1.5-3T) Total per rater: 240 hippos Assessment of variance due to rater and center Local Protocol ADNI scans: 2 x 5 Scheltens’s atrophy scores x 2 sides x 2 magnet strengths (1.5-3T) Harmonized Protocol ADNI scans: 2 x 5 Scheltens’s atrophy score x 2 sides x 2 magnet strength (1.5-3T) Total per rater: 40 hippos Harmonized Protocol: Pathological datasets: Mayo Clinic and NYU Total: about 40 hippos Training ADNI scans: 10 at 1.5T x 2 sides x 7 SUs x 2 tracing rounds Total per rater: 40 hippos 20 naïve tracers5 master tracers 1 tracer REFERENCE PROBABILISTIC MASKS with 95% C.I. QUALIFICATION Best 5 naïve tracers Assessment of variance due to side, trace-retrace, atrophy, time, scanner, rater TRAINING SET Assessment of agreement with volume on pathology or ex vivo MRI and correlation with neuronal density

GANTT